Cargando…

The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice

BACKGROUND: In some regions in Africa, elimination of onchocerciasis may be possible with mass drug administration, although there is concern based on several factors that onchocerciasis cannot be eliminated solely through this approach. A vaccine against Onchocerca volvulus would provide a critical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hess, Jessica A., Zhan, Bin, Torigian, April R., Patton, John B., Petrovsky, Nikolai, Zhan, Tingting, Bottazzi, Maria Elena, Hotez, Peter J., Klei, Thomas R., Lustigman, Sara, Abraham, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936747/ https://www.ncbi.nlm.nih.gov/pubmed/27387453 http://dx.doi.org/10.1371/journal.pntd.0004797

Ejemplares similares

Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans
por: George, Parakkal Jovvian, et al.
Publicado: (2019)

Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis
por: Luu, Lisa, et al.
Publicado: (2022)

Nodding syndrome (NS) and Onchocerca Volvulus (OV) in Northern Uganda
por: Lagoro, David Kitara, et al.
Publicado: (2017)

The Onchocerca volvulus Cysteine Proteinase Inhibitor, Ov-CPI-2, Is a Target of Protective Antibody Response That Increases with Age
por: Cho-Ngwa, Fidelis, et al.
Publicado: (2010)

Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus
por: Shey, Robert Adamu, et al.
Publicado: (2018)

Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23
por: Vlaminck, Johnny, et al.
Publicado: (2019)

Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum
por: Patton, John B., et al.
Publicado: (2018)

Human immune responses to infective stage larval-specific chitinase of filarial parasite, Onchocerca volvulus, Ov-CHI-1.
por: Wu, Yang, et al.
Publicado: (2003)

Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein
por: Njume, Ferdinand Ngale, et al.
Publicado: (2019)

Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection
por: Arumugam, Sridhar, et al.
Publicado: (2016)

Molecular and immunological characterization of hr44, a human ocular component immunologically cross-reactive with antigen Ov39 of Onchocerca volvulus
Publicado: (1995)

Performance evaluation of 3 serodiagnostic peptide epitopes and the derived multi-epitope peptide OvNMP-48 for detection of Onchocerca volvulus infection
por: Lagatie, Ole, et al.
Publicado: (2019)

The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates
por: Wang, Jing, et al.
Publicado: (2012)

Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice
por: Ryan, Nathan M., et al.
Publicado: (2021)

Ov2 is a modulator of OvHV-2 RTA mediated gene expression
por: Dry, Inga, et al.
Publicado: (2019)

Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to Onchocerca volvulus in Mice and Non-Human Primates
por: Ryan, Nathan M., et al.
Publicado: (2023)

Nouveau coronavirus (NcOV)
por: Bricaire, François
Publicado: (2013)

Evaluation of glycoprotein Ov8 as a potential antigen for an OvHV-2-specific diagnostic assay
por: Alhajri, Salim M., et al.
Publicado: (2018)

Deletion of gene OV132 attenuates Orf virus more effectively than gene OV112
por: Yamada, Yumiko, et al.
Publicado: (2022)

Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi
por: Zhan, Bin, et al.
Publicado: (2022)

Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2021)

Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines
por: Jiang, Jiu, et al.
Publicado: (2014)

Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis
por: Lustigman, Sara, et al.
Publicado: (2007)

The NR3B subgroup: an ovERRview
por: Tremblay, Annie M., et al.
Publicado: (2007)

Regulation of Ov2 by virus encoded microRNAs
por: Nightingale, Katie, et al.
Publicado: (2019)

Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1
por: Jiang, Jiu, et al.
Publicado: (2016)

The genome of Onchocerca volvulus, agent of river blindness
por: Cotton, James A., et al.
Publicado: (2016)

Concordance between Ov16 rapid diagnostic test(RDT) and Ov16 enzyme-linked immunosorbent assay (ELISA) for the diagnosis of onchocerciasis in areas of contrasting endemicity in cameroon
por: Ekanya, Relindis, et al.
Publicado: (2023)

Temperature‐sensitive Ovarian Carcinoma Cell Line (OvBH‐1)
por: Bar, Julia K., et al.
Publicado: (2002)

Adaptation and Validation of the Lithuanian-Language Version of the Olympic Value Scale (OVS)
por: Sukys, Saulius, et al.
Publicado: (2022)

ASimOV: A Framework for Simulation and Optimization of an Embedded AI Accelerator
por: Hwang, Dong Hyun, et al.
Publicado: (2021)

Diagnosis of Ovarian Vein Syndrome (OVS) by Computed Tomography (CT) Imaging: A Retrospective Study of 11 Cases
por: Wang, Ruizhi, et al.
Publicado: (2014)

Murine Oviductosomes (OVS) microRNA profiling during the estrous cycle: Delivery of OVS-borne microRNAs to sperm where miR-34c-5p localizes at the centrosome
por: Fereshteh, Zeinab, et al.
Publicado: (2018)

Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis
por: Jawahar, Shabnam, et al.
Publicado: (2021)

Andre{breve}i Rubl{llig}i{rlig}ov strasti po Andre{llig}i{rlig}u /
Publicado: (1998)

Molecular cloning of an immunodominant antigen of Onchocerca volvulus
Publicado: (1988)

Interruption of Onchocerca volvulus transmission in Northern Venezuela
por: Convit, Jacinto, et al.
Publicado: (2013)

Onchocerca volvulus Mimicking Metastatic Breast Carcinoma
por: Nava, Victor E., et al.
Publicado: (2020)

Outstanding insecurities concerning the use of an Ov16-based ELISA in the Amazonia onchocerciasis focus
por: Luz, Sérgio Luiz Bessa, et al.
Publicado: (2014)

Association between targeted somatic mutation (TSM) signatures and HGS‐OvCa progression
por: Lindley, Robyn A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6k04o348m70spqrqneasl34ka3